The letters by Gallieni et al.1 and Silver2 regarding our paper3 both provided interesting insights into heterotopic ossification (HO) post spinal cord injury (SCI). It is a pleasure to be able to respond to thoughtful responses. We agree with the comments of Gallieni et al.1 on the possible mechanism of warfarin treatment in preventing HO post SCI. The authors suggest that the positive effect of warfarin may be in response to its block on osteocalcin. Other studies have shown that warfarin's inhibition of osteocalcin leads to abnormal mineralization of bone matrix.4, 5, 6 Further, these studies suggest the effect of warfarin to be even more potent during embryonic stages of bone development. Hence, though warfarin may not directly impair mineralization of bone matrix, it has a potential role in disrupting the formation of mineral crystals on collagen microfibrils involved in bone development.
We also agree with the authors' comment that there is an increased risk of cardiovascular calcification due to warfarin; however, this is a complex relationship.1 This risk has been shown to occur in certain individuals with specific genetic variations in their carboxylation enzymes.7 As cited by the letter of Gallieni et al.1 and our article,3 this may lead to increased risk of hemorrhage.
Our review of the literature was based upon our well-defined methodology.8 The fact that warfarin appeared to have a protective effect in a retrospective study suggests that it has potential as a treatment; we agree that more research is needed before it can be considered as a treatment.3
Silver2 provided evidence for an association between delayed passive movement (after time for contracture formation), microtrauma and HO development. In a pre-post study, Daud et al.9 found that occurrence of HO was associated with the interval between admission to the SCI center and the initiation of passive movement therapy, P<0.005. A delay of 7 or more days of passive movement therapy post SCI was associated with an increased probability of HO development. Izumi10 in a study of paralyzed rabbits found passive movements following immobilization of a paralyzed rabbit resulted in heterotopic bone formation. Hence, it is clear that there is an association between delayed passive movements of paralyzed joints and the development of HO post SCI; it is arguable whether that is enough to constitute a causative relationship but the evidence provided makes a compelling case.
References
Gallieni M, Martini A, Fusaro M . Warfarin and heterotopic ossification: good, bad or ugly? Spinal Cord (this issue).
Silver JR . Letter to Editor of Spinal Cord. Spinal Cord. (this issue).
Teasell RW, Mehta S, Aubut JL, Ashe MC, Sequeira K, Macaluso S et al. A systematic review of the therapeutic interventions for heterotopic ossification after spinal cord injury. Spinal Cord 2010; 48: 512–521.
Amizuka N, Li M, Hara K, Kobayashi M, de Freitas PHL, Ubaidus S et al. Warfarin administration disrupts the assembly of mineralized nodules in the osteoid. J Electron Microsc 2009; 58: 55–62.
Pastoureau P, Vergnaud P, Meunier PJ, Delmas PD . Osteopenia and bone remodelling abnormalities in warfarin treated lambs. J Bone Miner Res 1993; 8: 1417–1426.
Rezaieyazdi Z, Falsoleiman H, Khajehdaluee M, Saghari M, Mokhtari-Amirmajdi E . Reduced bone density in patients on long-term warfarin. Int J Rheum Dis 2009; 12: 130–135.
Danziger J . Vitamin K-dependent proteins, warfarin, and vascular calcification. Clin J Am Soc Nephrol 2008; 3: 1504–1510.
Eng JJ, Teasell RW, Miller WC, Wolfe DL, Townson AF, Hsieh JTC et al.##(eds). Spinal Cord Injury Evidence: Methods of the SCIRE systematic review. Top Spinal Cord Inj Rehabil 2007; 13: 1–10.
Daud O, Sett P, Burr RG, Silver JR . The relationship of heterotopic ossification to passive movements in paraplegic patients. Disabil Rehabil 1993; 15: 114–118.
Izumi K . Study of ectopic bone formation in experimental spinal cord injured rabbits. Paraplegia 1083; 21: 351–363.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Mehta, S., Teasell, R. Reply to Gallieni et al. and Silver. Spinal Cord 49, 484 (2011). https://doi.org/10.1038/sc.2010.136
Published:
Issue Date:
DOI: https://doi.org/10.1038/sc.2010.136